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Background: There is signiﬁcant debate as to where to draw the line between undertreating older rectal
cancer patients and minimising treatment risks. This study sought to examine the use of radical rectal
cancer treatments and associated outcomes in relation to age across the English NHS.
Methods: Patient, tumour and treatment characteristics for all patients diagnosed with a ﬁrst primary
rectal cancer in England between 1st April 2009 and 31st December 2014 were obtained from the
CORECT-R data repository. Descriptive analyses and adjusted logistic regression models were undertaken
to examine any association between age and the use of major resection and post-surgical outcomes.
Funnel plots were used to show variation in adjusted rates of major resection.
Results: The proportion of patients who underwent a major surgical resection fell from 66.5% to 31.7%,
amongst those aged <70 and aged 80 respectively. After adjustment, 30-day post-operative mortality,
failure to rescue and prolonged length of stay were signiﬁcantly higher among the oldest group when
compared to the youngest. Patient reported outcomes were not signiﬁcantly worse amongst older pa-
tients. Signiﬁcant variation was observed in adjusted surgical resection rates in the oldest patients be-
tween NHS Trusts. The probability of death due to cancer was comparable across all age groups.
Conclusions: Older patients who are selected for surgery have good outcomes, often comparable to their
younger counterparts. Signiﬁcant variation in the treatment of older patients could not be explained by
differences in measured characteristics and required further investigation.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
In 2016 over 9000 rectal cancers were diagnosed in the UK, with
22.5% of these occurring in older patients (aged80) [1]. Increasing
life expectancy means that the proportion of the UK population
considered very old is predicted to double within the next 25 years
[2]. This is likely to result in an increasing number of cancers
diagnosed in old and very old people, making their treatment and
disease outcomes an important focus for policymakers. The English
National Health Service (NHS) is pushing to attain world classup, Leeds Institute for Data
eds, LS2 9NL, UK.
r Ltd. This is an open access article
tal cancer in old age eis it a
lth service, European Journacancer outcomes [3] and, to achieve this, it is vital that this large
population group receives the highest standard of care. Exactly
what constitutes gold standard care for older people is, however,
controversial. For example, currently there is major concern about
the under-treatment of older people. This has arisen from a
growing number of observational studies that have reported lower
treatment rates with increasing age [4e6]. In rectal cancer, rates of
use of many important treatments, including major surgical
resection, neoadjuvant radiotherapy and adjuvant chemotherapy,
have all been shown to decrease with increasing age [7,8] and this
has been hypothesised to be a contributory factor to UK rectal
cancer survival rates lagging behind their European counterparts
[4].
Others argue, however, that lower rates of treatment in olderunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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prevalence of poor prognostic factors including more comorbidity
[9e11], delayed presentation [12,13], and later stage disease [14].
These associations make the appropriate treatment rate in relation
to age difﬁcult to determine and it is vital they are factored into any
analysis investigating what constitutes ‘age appropriate’ care.
Furthermore, amongst those older people who are treated, out-
comes may be worse than those attained by their younger coun-
terparts. In rectal cancer the ﬁgures can be quite alarming, with
some studies demonstrating signiﬁcantly higher proportions dying
within 30-days of surgery amongst the oldest age groups [15e20].
This has led some to suggest that major resection may not be
appropriate amongst older patients when there is the possibility of
an alternative treatment [15]. Similarly, other surgical outcomes
such as length of stay in hospital, surgical complications [21] and
lower stoma reversal rates [22] may all beworse in older people. So,
whilst under-treatment may be a problem for older cancer patients,
over-treatment could be equally as important if quality of life is as
important as its duration [23]. Concerns have also been raised
about the importance clinicians place on various patient charac-
teristics related to age. It has been hypothesised that this leads to
the treatment of only those older patients with few adverse factors
whilst perceptions of increased risk mean that others, who may
have beneﬁtted from treatment, are not provided with the oppor-
tunity for optimal treatment [4,24]. There is a ﬁne balance, there-
fore, between selecting individuals for treatment to minimise risk
and not under-treating, or denying treatment, to older age groups.
More and better evidence is urgently required to help determine
optimal management strategies.
Currently, there is a growing availability of routinely collected
healthcare data and its analysis can produce the intelligence
needed to help inform the controversy of what constitutes age-
appropriate rectal cancer treatment. This study aims to use of
these data to examine the use of radical rectal cancer treatments
(both surgery and neoadjuvant radiotherapy) and their associated
outcomes, and assess how these varied across the English NHS. This
information is key in ensuring appropriate and informed treatment
for older rectal cancer patients, informing and training practi-
tioners, and delivering improvements in patient outcomes.
2. Methods
The COloRECTal cancer data Repository (CORECT-R) [25] links
National Cancer Registration and Analysis Service (NCRAS) data to
additional, routine national datasets (including both Hospital
Episode Statistics (HES) [26] and the Radiotherapy Dataset (RTDS)
[27]) to create the richest population-based colorectal dataset
possible. From this resource, information was obtained from the
National Cancer Registration and Analysis Service (NCRAS) [28]
dataset on all patients diagnosed with a ﬁrst primary rectal cancer
(ICD10 [29] code C20) in England between 1st April 2009 and 31st
December 2014. Information extracted included age, sex, stage of
disease at diagnosis, socioeconomic status (based on the income
domain of the Index of Multiple Deprivation (IMD) score), route to
diagnosis (RTD) [12,30] and survival time. For ease of interpreta-
tion, and in line with the various deﬁnitions of old age which have
been used by others [4,8,31], patients were grouped into the
following age groups; <70, 70e79 and 80 years at the time of
diagnosis.
Patient Reported Outcomes Measures (PROMs) data were
available for a subset of patients (patients diagnosed with colo-
rectal cancer between 2010 and 2011who survived between 12 and
36 months from diagnosis) and were linked into the CORECT-R
dataset [32]. Responders were categorised. Based on their EQ-5D
score, as having ‘perfect’ (no problems reported on EQ-5D) or lessPlease cite this article as: Birch RJ et al., Rectal cancer in old age eis it a
routine data across the English national health service, European Journathan perfect (one or more problems reported) [32]. The Social
Difﬁculties Inventory (SDI) was used to identify those displaying
high levels of social distress based on their score. A score of 10 or
more has previously been identiﬁed as indicating high levels of
social distress and so was used in this study with patients being
assigned to one of two groups based on their reposes to the 16
items contained in the SD-16 scale; no social distress e score <10,
high levels of social distress e score 10 [33,34]. For patients who
had a stoma an additional item from the PROMs questionnaire was
also examined regarding their level of embarrassment caused by
their stoma. Patients were assigned to one of three groups based on
their answer to this question (group one e not at all embarrassed,
group 2 e a little bit or somewhat embarrassed or group 3e quite a
bit or very much embarrassed).
Details of surgical management, including the use and type of
major surgical resection and whether it necessitated the formation
of a stoma, were obtained from the HES data in CORECT-R and
grouped according to standard algorithms [7,16]. Stoma reversal
was identiﬁed from procedure codes recorded in the 18 months
following its creation. Analysis of stoma reversal included only
patients who had survived a minimum of 18 months from stoma
creation. Information about neoadjuvant radiotherapy received
was obtained from the RTDS for patients who had undergone a
major surgical resection. Analysis of PROMs was undertaken to
examine the relationship between age and less than perfect health
and levels of embarrassment related to a stoma for patients who
reported that their stoma had not been reversed. Patients were
classiﬁed as having; no neoadjuvant radiotherapy, short course
radiotherapy with immediate surgery (SCRT-I), short course
radiotherapy with delayed surgery (SCRT-D) or long course chemo
radiotherapy (LCCRT) again according to standard algorithms [35].
A Charlson comorbidity score was obtained for each patient, based
on diagnostic codes (excluding cancer) recorded during any
admission to hospital in the year preceding diagnosis. The cancer
component of the score, cancer diagnoses prior to the colorectal
cancer in question, were derived from the registry data.
For patients who underwent a major surgical resection addi-
tional variables were derived; Thirty-day post-operative mortality
was deﬁned as a death within 30 days of a major surgical resection
[16]. Length of stay (LOS) was deﬁned as the time (in days) between
major surgical resection and discharge from hospital or death in
hospital, whichever occurred ﬁrst [21]. Prolonged LOS was deﬁned
as being a stay of 21 or more days from surgery [21]. A return to
theatre was ﬂagged if an individual was reported as having a pro-
cedure to manage a surgical complication within 28 days of their
major surgical resection. Failure to rescue was deﬁned as a death
within 28 days of a major surgical resectionwhich occurred after at
least one return to theatre. Emergency readmission was deﬁned as
an emergency admission within 30 days of discharge from the
surgical inpatient spell.
Further statistical analyses were conducted limited to the oldest
patients (80). Multilevel binary logistic regression models were
used to assess the factors associated with the probability receipt of
a major surgical resection. The models were built with patients
clustered within NHS Trusts, allowing for differing population de-
mographics and correlated outcomes between trusts. The explan-
atory variables included were sex, IMD category, year of diagnosis
(included as a continuous variable), Charlson comorbidity score,
stage of disease and route to diagnosis (emergency or non-
emergency). The outcome of interest was major resection,
included as a binary outcome. Funnel plots, produced using the
Spiegelhalter method [16,36], were used to compare operative
rates between Trusts with the adjusted operative rate plotted
against the workload.
Adjusted logistic regression models were used to calculate theppropriately managed? Evidence from population-based analysis of
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rescue, emergency readmission, prolonged length of stay, creation
of a stoma during an anterior resection and the presence of a stoma
at 18months from creation. Each outcomewasmodelled separately
and adjusted for age, sex, IMD, Charlson score, stage of disease, year
of diagnosis and route to diagnosis (emergency or non-emergency).
With the exception of the stoma outcomes, models included all
patients who had undergone a major surgical resection of their
cancer and included adjustment for the type of operation which
was performed (anterior resection, abdominoperineal excision,
Hartmann's procedure or other). Further models were produced to
examine the odds of less than perfect health or high levels of social
distress, as reported in the PROMs data, for patients who under-
went a major surgical resection.
Crude probabilities of death due to cancer and due to other
causes were calculated for each age and surgical group to allow for
an assessment of the probability of dying from cancer in the
presence of competing risks [37,38]. Calculations were performed
in Stata 15.0 using the strs command with the cuminc option.
All statistical analysis was undertaken using Stata 15.0 (State
College, Tx, USA).
3. Results
In total, 52,922 people were diagnosed with a ﬁrst primary
rectal cancer in England over the study period. Of these, 11,924
(22.4%) were aged 80 at the time of diagnosis (Table 1). A greater
proportion of older patients had characteristics associated with
poor outcomes compared to their younger counterparts. For
example 8.7% of patients aged 80 had a Charlson score of 3
compared to 1.6% of those aged <70 and 21.3% of patients aged80
were diagnosed as an emergency compared to 7.5% of those aged
<70 (Table 1).Overall, 30,134 patients (56.9%) received a major
surgical resection. The proportion undergoing a major resection
decreased with age, falling from 66.5% amongst those aged <70 to
31.7% amongst those aged 80 (Table 1).
In patients undergoing major surgical resection, the use of
neoadjuvant radiotherapy decreased with age, with 48.4% of those
<70 receiving no radiotherapy compared to 69.5% of those aged
80. The use of LCCRT fell (35.4%e12.3%) but was not accounted for
by a corresponding increase in the use of SCRT-D, which increased
from 0.9% to 4.3% between the youngest and oldest patient groups
(Table 1). Little variation in the use of postoperative radiotherapy
was identiﬁed in relation to age group (Table 1).
The rate of stoma creation during an anterior resection was
similar across all age groups (73.9%, 71.8% and 65.6% respectively).
The proportion of patients with a stoma present 18 months from
creation, however, increased signiﬁcantly with age, from 30.6%
amongst those aged <70 to 54.0% amongst those aged 80 (Fig. 1).
The proportion of patients reporting less than ‘perfect’ health in the
presence of a permanent stoma did not differ signiﬁcantly between
age groups. Older patients reported lower levels of embarrassment
associated with a stoma than their younger counterparts (Fig. 2).
Deaths within 30 days of a major surgical resection increased
with age, from 1.0% to 5.5% in the youngest and oldest groups
(Fig. 3). The rate of returns to theatre were relatively consistent
between age groups (11.0%, 11.6% and 10.2% respectively) (Fig. 3).
Having at least one return to theatre after initial surgery was
associated with an increased rate of 30-day post-operative mor-
tality (compared to those who did not return to theatre) and this
was consistent across all age groups (Fig. 3). No signiﬁcant differ-
ence was identiﬁed in 30-day post-operative mortality between
those who received neoadjuvant radiotherapy and those who did
not amongst the oldest patients (p> 0.05 results not presented)
(Table 2).Please cite this article as: Birch RJ et al., Rectal cancer in old age eis it a
routine data across the English national health service, European JournaSubstantial variation in the use of major resection amongst the
oldest patients was observed between NHS Trusts in England (rates
ranging from 9.7% to 54.2%) (Fig. 4a). After adjustment for casemix
factors (sex, IMD category, Charlson comorbidity score, year of
diagnosis and stage of disease) signiﬁcant variation was still
observed in operative rates for the oldest patients between NHS
Trusts in England (Fig. 4b).
Signiﬁcant variation in 30-day post-operative mortality, failure
to rescue, prolonged length of stay and the presence of a stoma at
18 months from creation was identiﬁed in relation to age. In
adjusted models the odds of all these outcomes was signiﬁcantly
higher amongst the oldest patients compared to the youngest pa-
tients. The odds of an emergency readmission or creation of a stoma
during an anterior resection fell signiﬁcantly when comparing the
oldest group to the youngest. No signiﬁcant difference between age
groups was identiﬁed in relation to the odds of a return to theatre
(Fig. 5). No signiﬁcant difference between age groups was observed
in relation to the odds of less than perfect health after a major
surgical resection. The odds of high levels social distress were
signiﬁcantly lower amongst individuals aged 70e79 (OR 0.47 95%CI
0.39e0.57) or 80 (OR 0.59 95%CI 0.43e0.80) than those aged <70
(Fig. 6).
Across all age groups the estimated probability of death due to
cancer was higher amongst those who did not undergo a major
surgical resection. Despite the probability of death due to other
causes increasing with age the probability of death due to cancer
was comparable between age groups in both treatment categories
(major resection and no major resection) (Fig. 7). Within the oldest
group (80) who underwent a major resection 9.8% of patients
were predicted to die, due to cancer, within 24months of diagnosis,
compared to 5.9% of those aged< 70. In contrast deaths due to
other causes rose signiﬁcantly with 14.5% of all patients aged 80
who underwent a major resection dying due to other causes within
24 months of diagnosis, compared to only 1.6% of those aged <70.
4. Discussion
This comprehensive analysis of national, population-based
datasets of rectal cancers managed within the English NHS pro-
vides valuable information to inform the management of older
people. It has shown that, although the risks of radical treatment
are greater in older people their outcomes can be comparable to
those obtained in younger age groups. It also demonstrated, how-
ever, that older people were signiﬁcantly less likely to receive
potentially curative treatments than their younger counterparts
and, although contributory to it, this variation is not fully explained
by differences in the distribution of important prognostic factors
related to age (and that can be measured in routine data) such as
increasing Charlson comorbidity score or stage of disease. Signiﬁ-
cant variation was also apparent in how different NHS hospital
Trusts actively managed older patients and this, again, was not
explained by casemix differences. Minimising these variations is
vital to improve rectal cancer care and outcomes in the NHS. There
were, however, other relevant factors, such as frailty and patient
choice, which were not quantiﬁed in the available data and which
may contribute to the variation observed.
These data should help both patients and the multidisciplinary
teams who manage them to make informed decisions about
treatment. For example, when surgeons discuss treatment options
with older rectal cancer patients they can refer to this very large
‘real world’ study of the results achieved in the English NHS when
they are considering the roll of radical surgery to inform patients of
the risks and beneﬁts of treatment.
The oldest patients were less likely than their younger coun-
terparts to undergo a major surgical resection or neoadjuvantppropriately managed? Evidence from population-based analysis of
l of Surgical Oncology, https://doi.org/10.1016/j.ejso.2019.01.005
Table 1
Characteristics of the study population.
<70 70e79 80 Total
n % n % n % n %
Characteristics
Sex Male 16,719 65.8 10,250 65.8 6514 54.6 33,483 63.3
Female 8704 34.2 5325 34.2 5410 45.4 19,439 36.7
Socioeconomic status 1 - most afﬂuent 5566 21.9 3451 22.2 2633 22.1 11,650 22.0
2 5662 22.3 3560 22.9 2668 22.4 11,890 22.5
3 5337 21.0 3211 20.6 2552 21.4 11,100 21.0
4 4746 18.7 2929 18.8 2282 19.1 9957 18.8
5 - most deprived 4112 16.2 2424 15.6 1789 15.0 8325 15.7
Charlson comorbidity score 0 21,151 83.2 10,924 70.1 7218 60.5 39,293 74.2
1 3196 12.6 2968 19.1 2540 21.3 8704 16.4
2 679 2.7 960 6.2 1126 9.4 2765 5.2
3 397 1.6 723 4.6 1040 8.7 2160 4.1
Stage of disease I 4837 19.0 3091 19.8 1756 14.7 9684 18.3
II 3999 15.7 2868 18.4 1948 16.3 8815 16.7
III 7640 30.1 4093 26.3 2262 19.0 13,995 26.4
IV 4064 16.0 2374 15.2 1800 15.1 8238 15.6
Unknown 4883 19.2 3149 20.2 4158 34.9 12,190 23.0
Route to diagnosis GP referral 6981 27.5 4183 26.9 3303 27.7 14,467 27.3
TWW 9379 36.9 6758 43.4 4747 39.8 20,884 39.5
Emergency 1899 7.5 1606 10.3 2542 21.3 6047 11.4
Other outpatient 1430 5.6 960 6.2 743 6.2 3133 5.9
Screening 3711 14.6 1313 8.4 44 0.4 5068 9.6
Inpatient elective 1168 4.6 500 3.2 356 3.0 2024 3.8
Unknown 855 3.4 255 1.6 189 1.6 1299 2.4
Total 25,423 15,575 11,924 52,922
Management
Surgical management Major resection 16,917 66.5 9440 60.6 3777 31.7 30,134 56.9
Minor resection 2902 11.4 1857 11.9 1551 13.0 6310 11.9
Palliative procedure 1536 6.0 975 6.3 927 7.8 3438 6.5
No surgery 4068 16.0 3303 21.2 5669 47.5 13,040 24.6
Total 25,423 15,575 11,924 52,922
Operation type APE 4055 24.0 2324 24.6 880 23.3 7259 24.1
Anterior resection 10,667 63.1 5591 59.2 1910 50.6 18,168 60.3
Hartmann's 903 5.3 838 8.9 713 18.9 2454 8.1
Other 1292 7.6 687 7.3 274 7.3 2253 7.5
Total 16,917 9440 3777 30,134
Radiotherapya None 8164 48.4 5218 55.4 2608 69.5 15,990 53.2
SCRT-I 1994 11.8 1142 12.1 353 9.3 3489 11.6
SCRT-D 149 0.9 130 1.4 160 4.2 439 1.5
LCCRT 5995 35.4 2563 27.2 465 12.3 9023 29.9
PORT 333 2.0 186 2.0 83 2.2 602 2.0
ORT 250 1.5 179 1.9 86 2.3 515 1.7
Total 16,917 9440 3777 30,134
a SCRT-I e short course radiotherapy with immediate surgery, SCRT-De short course radiotherapy with delayed surgery, LCCRT e long course chemo radiotherapy, PORTe
post-operative radiotherapy, ORT e other radiotherapy.
Fig. 1. Stoma creation and closure rates for patients who underwent an anterior resection, by age at diagnosis.
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Fig. 2. a: Results from PROMs data for patients whose stoma was not reversed -
'Perfect' health. b: Results from PROMs data for patients whose stomawas not reversed
- Embarrassed by stoma.
Table 2
30-day post-operative mortality and neoadjuvant radiotherapy, by age.




n % n %
No neoadjuvant radiotherapy <70 8064 98.8 100 1.2 8164
70e79 5049 96.8 169 3.2 5218
80 2455 94.1 153 5.9 2608
Overall 15,588 97.4 422 2.6 16,010
Any neoadjuvant radiotherapy <70 8080 99.3 58 0.7 8138
70e79 3736 97.4 99 2.6 3835
80 932 95.3 46 4.7 978
Overall 12,748 98.4 203 1.6 12,951
R.J. Birch et al. / European Journal of Surgical Oncology xxx (xxxx) xxx 5radiotherapy as a treatment for rectal cancer. Our data shows that
some of this reduction is associated with clinical characteristics
such as comorbidity and appears to reﬂect appropriate case selec-
tion inmany cases. Our data do hint that patients, clinicians, or both
may give a greater weight to comorbidity in older patients when
making decisions. The measure of comorbidity used in this study is,
however, blunt, identifying comorbid conditions through inpatient
admission records. A more robust measure may offer greater
insight into speciﬁc conditions or health needs that may contributeFig. 3. 30-day post-operative mortality and return to surgery rates for pat
Please cite this article as: Birch RJ et al., Rectal cancer in old age eis it a
routine data across the English national health service, European Journato this. Under some circumstances avoiding surgery in older people
may be appropriate if clinicians are concerned about risk factors
that are not identiﬁable from routine data. If, however, the variation
seen is a result of an inappropriate emphasis on chronological age
then action must be taken to ensure no-one is denied potentially
curative treatment.
Amongst the oldest patients it is of note that the probability of
death due to cancer amongst those who underwent a major sur-
gical resection for their rectal tumour was lower than the proba-
bility of death due to other causes and was, in fact, comparable to
the probabilities observed amongst the youngest patients. Sup-
porting the suggestion that the oldest patients can achieve out-
comes in line with those of their younger counterparts. For those
who did undergo a major resection of their tumour, older patients
were no more likely to report less than perfect health than their
younger counterparts. In contrast, older patients were in fact less
likely to report high levels of social distress than younger patients
following major surgery for their rectal cancer. Older patients often
rate quality of life as being more important to them than higher
duration of survival [23,39]. The ﬁndings of this study demonstrate
that there does not appear to be a direct relationship between
increasing age, intensity of treatment, and poor quality of life,
suggesting that this should not be a reason not to offer treatment.
Deaths within 30-days of surgery increased with age, but even
in the oldest patients failed to reach the rate cited by others as anients who underwent a major surgical resection, by age at diagnosis.
ppropriately managed? Evidence from population-based analysis of
l of Surgical Oncology, https://doi.org/10.1016/j.ejso.2019.01.005
Fig. 5. Results of adjusted logistic regression models in relation to age group. Each outcome modelled separately (full results of adjusted models available in Appendix A & C).
Fig. 4. a: Variation in the use of major surgical resection for patients aged 80 by NHS Trust. b: Adjusted funnel plot showing rate of resection for patients aged 80 by NHS Trust.
R.J. Birch et al. / European Journal of Surgical Oncology xxx (xxxx) xxx6unacceptable risk [15,20]. While returns to surgery were similar
across age groups, deaths within 30-days amongst patients who
had returned to surgery increased with age to a greater extent than
was seen amongst those with no returns to surgery. The reasons for
this are unclear and require further investigation, but may reﬂect
the reduced ability of the oldest patients to cope with thePlease cite this article as: Birch RJ et al., Rectal cancer in old age eis it a
routine data across the English national health service, European Journaphysiological insult necessitating the return to theatre.
Notably individuals receiving neoadjuvant radiotherapy did not
have higher rates of post-operative mortality, irrespective of age.
The concern that the use of radiotherapy might worsen post-
operative outcomes disproportionately in the older age group is
not justiﬁed by these data. There is undoubtedly a signiﬁcantppropriately managed? Evidence from population-based analysis of
l of Surgical Oncology, https://doi.org/10.1016/j.ejso.2019.01.005
Fig. 7. Crude probability of death by age group and surgical management.
Fig. 6. Results of adjusted logistic regression models in relation to age group. Each outcome modelled separately (full results of models available in Appendix D).
R.J. Birch et al. / European Journal of Surgical Oncology xxx (xxxx) xxx 7element of case selection currently which requires further inves-
tigation, as does the ﬁnding that reduced use of LCCRT in the older
age group is not compensated for by increased use of SCRT-D.
Whilst surgery remains the gold standard of care, there is an
increasing recognition of the potential role of chemoradiotherapy
or radiotherapy alone as a curative treatment, particularly in those
considered to be at high operative risk. This cannot be addressed
with the available data. This alternative treatment is likely only to
be used in a very small number of cases, with access to contact
brachytherapy in particular varying markedly across the country.Please cite this article as: Birch RJ et al., Rectal cancer in old age eis it a
routine data across the English national health service, European JournaOn this basis it seems unlikely that non-surgical approaches are
signiﬁcantly impacting upon the overall results seen here, although
thesemay explain some speciﬁc areas of the geographical variation.
This study shows stoma reversal rates are lower in older pa-
tients. Studies have reported that stomas in older patients are not
associated with the reduction in quality of life which is often seen
amongst younger patients, and some studies suggest stomas may
be associated with an improved quality of life amongst older pa-
tients [40e42], meaning that non reversal is not necessarily a
negative outcome. This is supported by ﬁndings from the PROMsppropriately managed? Evidence from population-based analysis of
l of Surgical Oncology, https://doi.org/10.1016/j.ejso.2019.01.005
R.J. Birch et al. / European Journal of Surgical Oncology xxx (xxxx) xxx8data used in this study which found no difference in reported
‘perfect’ health between age groups. Further work is needed to
determine whether low reversal rates are due to patient choice,
surgeon choice or reﬂect advanced stage of presentation.
Further casemix information is needed in order to truly under-
stand the variation observed between Trusts. NBOCA collects in-
formation about the reason why patients did not undergo a major
resection, including too little cancer, toomuch cancer, high levels of
frailty and other/unknown reasons. An assessment of any variation
in these factors between Trusts could provide important additional
information regarding the selection process [43].
A signiﬁcant limitation of this study is that it includes no mea-
sure of patient choice. Some have suggested that older patientsmay
be more likely to refuse treatment as they often rate quality of life
over quantity [23,44]. However, a recent study of 1500 patients
found that older patients were no more likely to refuse treatment
which is offered than their younger counterparts [45]. This ﬁnding
suggests that treatment refusal is unlikely to account for the fall in
treatment rates observed, but further work to assess patient choice
and shared decision making is key to understanding differences in
observed treatment rates.5. Conclusions
This study provides the ﬁrst comprehensive, population-based,
description of the initial management of rectal cancer patients in
the English NHS. It demonstrates that older patients undergoing
treatment for rectal cancer have comparable outcomes to their
younger counterparts. It identiﬁes important shortfalls in uptake of
major treatments and suggests explanations. Understanding these
issues should inform policy and service planning and practice
within MDTs. Greater national consistency should improve out-
comes, which remain relatively poor in older patients.Declarations
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